Results 21 to 30 of about 21,822 (212)

M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p. [PDF]

open access: yesPLoS ONE, 2012
The M(3) subtype of muscarinic acetylcholine receptors (M(3)-mAChR) plays a protective role in myocardial ischemia and microRNAs (miRNAs) participate in many cardiac pathophysiological processes, including ischemia-induced cardiac injury.
Zhenyu Pan   +14 more
doaj   +1 more source

Role of atrial natriuretic peptide in abrogated cardio protective effect of ischemic postconditioning in diabetic rat heart

open access: yesBiomedical and Biotechnology Research Journal, 2022
Background: Diabetes decreased cardioprotective potential of ischemic postconditioning (IPOC), atrial natriuretic peptide (ANP) induced the cardioprotection against ischemic-reperfusion (I/R) injury. The present study has been designed to investigate the
Garima Gupta   +4 more
doaj   +1 more source

Role of Macrophages in Cardioprotection [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Cardiovascular diseases are the leading cause of mortality worldwide. It is widely known that non-resolving inflammation results in atherosclerotic conditions, which are responsible for a host of downstream pathologies including thrombosis, myocardial infarction (MI), and neurovascular events.
Jonathan Yap   +4 more
openaire   +4 more sources

Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes [PDF]

open access: yesKorean Journal of Anesthesiology, 2011
During the past few decades, a large number of animal studies demonstrated that commonly used opioids could provide cardioprotection against ischemia-reperfusion (I/R) injury.
Jin Mo Kim, Young Ho Jang, Jun Kim
doaj   +1 more source

Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I

open access: yesActa Pharmaceutica Sinica B, 2021
Disrupted redox status primarily contributes to myocardial ischemia/reperfusion injury (MIRI). NRF2, the endogenous antioxidant regulator, might provide therapeutic benefits.
Hao Zeng   +8 more
doaj   +1 more source

Cardioprotection [PDF]

open access: yesCirculation, 2008
Over the past 2 to 3 decades, several phenomena have been identified that provide powerful protection against myocardial infarction and other sequelae of ischemia/reperfusion1: myocardial hibernation that is related to stunning,2 ischemic preconditioning,3 delayed or second-window ischemic preconditioning,4 ischemic postconditioning,5 and their ...
Gerd Heusch   +2 more
openaire   +1 more source

N-Acetylcysteine Restores Sevoflurane Postconditioning Cardioprotection against Myocardial Ischemia-Reperfusion Injury in Diabetic Rats

open access: yesJournal of Diabetes Research, 2016
The effect of sevoflurane postconditioning (sevo-postC) cardioprotection is compromised in diabetes which is associated with increased oxidative stress. We hypothesized that antioxidant N-Acetylcysteine may enhance or restore sevo-postC cardioprotection ...
Jiefu Lin   +6 more
doaj   +1 more source

Identifying the Source of a Humoral Factor of Remote (Pre)Conditioning Cardioprotection.

open access: yesPLoS ONE, 2016
Signalling pathways underlying the phenomenon of remote ischaemic preconditioning (RPc) cardioprotection are not completely understood. The existing evidence agrees that intact sensory innervation of the remote tissue/organ is required for the release ...
Svetlana Mastitskaya   +5 more
doaj   +1 more source

TAT-protein blockade during ischemia/reperfusion reveals critical role for p85 PI3K-PTEN interaction in cardiomyocyte injury. [PDF]

open access: yesPLoS ONE, 2014
Recent work shows that cooling protection after mouse cardiac arrest and cardiomyocyte ischemia is mediated by Akt activation. The PI3K p85 subunit can either augment or inhibit Akt activation depending on its binding to p110 or PTEN respectively.
Xiangdong Zhu   +9 more
doaj   +1 more source

Doxorubicin-induced cardiotoxicity and risk factors

open access: yesInternational Journal of Cardiology: Heart & Vasculature
Doxorubicin (DOX) is an anthracycline antibiotic widely used as a chemotherapeutic agent to treat solid tumours and hematologic malignancies. Although useful in the treatment of cancers, the benefit of DOX is limited due to its cardiotoxic effect that is
Carl Belger   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy